Heitmann, J. S., Walz, J. S., Pflügler, M., Kauer, J., Schlenk, R. F., Jung, G., & Salih, H. R. (2020). Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma. BMJ Open.

Heitmann, Jonas S., Juliane S. Walz, Martin Pflügler, Joseph Kauer, Richard F. Schlenk, Gundram Jung, a Helmut R. Salih. "Protocol of a Prospective, Multicentre Phase I Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration-resistant Prostate Carcinoma." BMJ Open 2020.

Heitmann, Jonas S., et al. "Protocol of a Prospective, Multicentre Phase I Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration-resistant Prostate Carcinoma." BMJ Open 2020.